Nusinersen injections in adults and children with spinal muscular atrophy: a single-center experience | Zendy

Can Özütemiz | Zendy; Peter Karachunski | Zendy; David Nascene | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nusinersen injections in adults and children with spinal muscular atrophy: a single-center experience

Author(s) -

Can Özütemiz,

Peter Karachunski,

David Nascene

Publication year - 2020

Publication title -

diagnostic and interventional radiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.754

H-Index - 43

eISSN - 1305-3612

pISSN - 1305-3825

DOI - 10.5152/dir.2020.19607

Subject(s) - medicine , sma* , spinal muscular atrophy , surgery , lumbar , sedation , cohort , fluoroscopy , single center , anesthesia , lumbar puncture , disease , mathematics , cerebrospinal fluid , combinatorics

Nusinersen is a drug approved in December 2016 for treatment of spinal muscular atrophy (SMA). We want to share our initial experience with image-guided, non-image-guided, and port-delivered nusinersen injections in a large single-center SMA patient cohort, treating both pediatric and adult patients with focus on technical considerations and other patient concerns from a combined perspective of patient, neurologist, and radiologist.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research